Page results
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
This page has been written for parents and carers whose child is having total body irradiation (TBI) for leukaemia, lymphoma, or some other rare blood disorder.
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the spine (backbone).
-
New precision therapy for bile duct cancer extends patients’ lives
-
Information about endovascular treatments of AVMs undertaken in the NHNN angiography suite.
-
Information about coil embolisations and how endovascular treatment is used to treat cerebral aneurysms.
-
Cancer surgery at UCLH on Operation Ouch
-
This page is for parents and carers whose child is having radiotherapy treatment to the pelvis.
-
John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.
File results
-
FOI/2023/0353 - Junior doctors remuneration for days on strike/will be on strike
-
FOI/2023/0352 - Data security training, data breach reporting, security budgets
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI201730 Cancelled cancer operations
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology